Versant Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $126K | Buy |
387
+51
| +15% | +$16.6K | 0.02% | 594 |
|
|
2025
Q1 | $90.7K | Buy |
336
+146
| +77% | +$39.4K | 0.02% | 663 |
|
|
2024
Q4 | $44.7K | Buy |
190
+83
| +78% | +$19.5K | 0.01% | 628 |
|
|
2024
Q3 | $29.4K | Buy |
107
+45
| +73% | +$12.4K | 0.01% | 644 |
|
|
2024
Q2 | $15.1K | Buy |
62
+59
| +1,967% | +$14.3K | ﹤0.01% | 817 |
|
|
2024
Q1 | $448 | Sell |
3
-6
| -67% | -$896 | ﹤0.01% | 1723 |
|
|
2023
Q4 | $1.72K | Buy |
9
+5
| +125% | +$957 | ﹤0.01% | 1342 |
|
|
2023
Q3 | $708 | Sell |
4
-1
| -20% | -$177 | ﹤0.01% | 1627 |
|
|
2023
Q2 | $950 | Buy |
5
+2
| +67% | +$380 | ﹤0.01% | 1618 |
|
|
2023
Q1 | $601 | Hold |
3
| – | – | ﹤0.01% | 1559 |
|
|
2022
Q4 | $713 | Hold |
3
| – | – | ﹤0.01% | 1376 |
|
|
2022
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 1176 |
|
|
2022
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 1428 |
|
|
2022
Q1 | $0 | Sell |
3
-6
| -67% | – | ﹤0.01% | 1442 |
|
|
2021
Q4 | $2K | Hold |
9
| – | – | ﹤0.01% | 1093 |
|
|
2021
Q3 | $2K | Buy |
9
+2
| +29% | +$444 | ﹤0.01% | 1092 |
|
|
2021
Q2 | $1K | Buy |
7
+4
| +133% | +$571 | ﹤0.01% | 1222 |
|
|
2021
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 1507 |
|
|
2020
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 1325 |
|
|
2020
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 1285 |
|
|
2020
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 1273 |
|
|
2020
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 1284 |
|
|
2019
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 1338 |
|
|
2019
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 1354 |
|
|
2019
Q2 | $0 | Sell |
3
-4
| -57% | – | ﹤0.01% | 1379 |
|
|
2019
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 1539 |
|
|
2018
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 1457 |
|
|
2018
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 1502 |
|
|
2018
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 1491 |
|
|
2018
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 1470 |
|
|
2017
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 1513 |
|
|
2017
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 1430 |
|
|
2017
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 1423 |
|
|
2017
Q1 | $0 | Buy |
+7
| New | – | ﹤0.01% | 1419 |
|